Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
MARY TAGLIAFERRI Insider Profile
4 Followers
MARY TAGLIAFERRI, Director at Enzo Biochem, holds 312.38K shares in Enzo Biochem (Ticker: ENZ), holds ― shares in RayzeBio, Inc. (Ticker: RYZB), holds 8.15K shares in Y-Mabs Therapeutics (Ticker: YMAB).
MARY TAGLIAFERRI has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that MARY TAGLIAFERRI holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by MARY TAGLIAFERRI
MARY TAGLIAFERRI's Trading History
Enzo Biochem
Feb 02, 2024
Director
Uninformative Buy
―
$188.99K
RayzeBio, Inc.
―
―
―
―
Y-Mabs Therapeutics
Jun 13, 2024
Director
Uninformative Buy
―
$48.69K
List of latest transactions for each holding click on a transaction to see MARY TAGLIAFERRI's performance on stock
You May Also Like
MARY TAGLIAFERRI insider profile FAQ
What is the percentage of profitable transactions made by MARY TAGLIAFERRI?
The percentage of profitable transactions made by MARY TAGLIAFERRI is ―.
What is the average return per transaction made by MARY TAGLIAFERRI?
The average return per transaction made by MARY TAGLIAFERRI is ―.
What stocks does MARY TAGLIAFERRI hold?
MARY TAGLIAFERRI holds: ENZ, RYZB, YMAB stocks.
What was MARY TAGLIAFERRI’s latest transaction?
MARY TAGLIAFERRI latest transaction was an Uninformative Buy of ―.
What was MARY TAGLIAFERRI's most profitable transaction?
MARY TAGLIAFERRI’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is MARY TAGLIAFERRI's role in Enzo Biochem?
MARY TAGLIAFERRI's role in Enzo Biochem is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.